At a glance
ClinicalIndex Comparison RecordEarly Ph 1Completed· 71 enrolled
Drug / intervention
Tranexamic Acid +1 moredrug
Likely dose
Not stated in record
Structured eligibility isn't available for this trial yet — see the full criteria in the Eligibility tab below.
Standardized by ClinicalIndex from the ClinicalTrials.gov record · verify against the source.
IV Tranexamic Acid Prior to Hysterectomy for Reduction of Intraoperative Blood Loss: A Randomized Placebo-Controlled Trial
In Brief
A Early Phase 1 clinical trial evaluating Tranexamic Acid and Sodium Chloride for Hysterectomy and Blood Loss, Surgical. Completed, enrolled 71 participants across 1 site.
Detailed Summary
The objective of this study is to determine the effect of 1g of IV tranexamic acid given within 1 hour pre-operatively on intraoperative blood loss at time of hysterectomy.
Study Details
Study Typeinterventional
Allocation--
Masking--
Primary Purpose--
ConditionsHysterectomy, Blood Loss, Surgical
CountriesUnited States
Collaborators--
Timeline
Early Ph 1CompletedFinished
2017201820192020202120222023202420252026
First PostedSep 2016
Enrollment StartNov 2016
Primary CompletionApr 2022
TodayJul 2026
First PostedSep 22, 2016
Enrollment StartNov 1, 2016
Primary CompletionApr 1, 2022
TodayJul 2, 2026
Enrollment to primary: 5.4 yearsPosted 9.8 years ago
Interventions
Tranexamic Aciddrug
Sodium Chloridedrug